Fresenius Medical Care - Champlin is a medicare approved dialysis facility center in Champlin, Minnesota and it has 24 dialysis stations. It is located in Hennepin county at 12339 Champlin Dr, Champlin, MN, 55316. You can reach out to the office of Fresenius Medical Care - Champlin at (763) 421-1032. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care - Champlin has the following ownership type - Profit. It was first certified by medicare in March, 2005. The medicare id for this facility is 242560 and it accepts patients under medicare ESRD program.
| Name | Fresenius Medical Care - Champlin |
|---|---|
| Location | 12339 Champlin Dr, Champlin, Minnesota |
| No. of Dialysis Stations | 24 |
| Medicare ID | 242560 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 12339 Champlin Dr, Champlin, Minnesota, 55316 | |
| (763) 421-1032 | |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
| NPI Number | 1992810741 |
| Organization Name | Fresenius Medical Care Of Champlin |
| Doing Business As | Bio-medical Applications Of Minnesota, Inc. |
| Address | 12339 Champlin Dr Champlin, Minnesota, 55316 |
| Phone Number | (763) 421-1032 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 20 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 10 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 36 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 293 |
| Percentage of adult patients getting regular hemodialysis at the center | 100 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care - Champlin with elevated calcium levels.
| Patients with hypercalcemia | 37 |
| Hypercalcemia patient months | 302 |
| Patients with Serumphosphor | 46 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 28 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 30 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 27 |
| Patients with Serumphosphor greater than 7 mg/dL | 8 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 57 |
| Patient months included in arterial venous fistula and catheter summaries | 281 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 76 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 33 |
| Hospitalization Rate in facility | 189.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 365.6 |
| Hospitalization Rate: Lower Confidence Limit | 103.3 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at Fresenius Medical Care - Champlin were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 38.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 50.2 |
| Readmission Rate: Lower Confidence Limit | 26.8 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Medical Care - Champlin get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.53 (As Expected) |
| SIR: Upper Confidence Limit | 4.15 |
| SIR: Lower Confidence Limit | .39 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care - Champlin's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 25 |
| Transfusion Rate in facility | 6.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 232.3 |
| Transfusion Rate: Lower Confidence Limit | .3 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
The rate of mortality show you whether patients who were being treated regularly at Fresenius Medical Care - Champlin lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 170 |
| Mortality Rate in facility | 12.9 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 19.7 |
| Mortality Rate: Lower Confidence Limit | 8 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago
Fresenius Medical Care - Champlin Location: 12339 Champlin Dr, Champlin, Minnesota, 55316 Phone: (763) 421-1032 |
News Archive
Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, today announced the first patient enrollment in a U.S. clinical study of CleanSweep Closed Suction System at Duke University Hospital in Durham, NC.
Using proteomics techniques to study injured optic nerves, researchers at Boston Children's Hospital have identified previously unrecognized proteins and pathways involved in nerve regeneration. Adding back one of these proteins-the oncogene c-myc-they achieved unprecedented optic nerve regeneration in mice when combined with two other known strategies.
Anavex Life Sciences Corp. ("Anavex") (OTCQB: AVXL) today announced that it has been invited to submit a full grant application to the Alzheimer's Drug Discovery Foundation ("ADDF") for a Phase 2a trial of ANAVEX 2-73.
Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
› Verified 8 days ago